Supply Chain

Software is making supply chain automation a long hoped for reality and the biggest reason your hospital is likely to get on board is money.

Healthcare systems have used value analysis since the 1990s, but the process is gaining more prominence amid the uncertainty created by healthcare reform and other changes in the way hospitals are reimbursed.

Although a May 2014 U.S. District Court ruling vacated HRSA's 340B orphan drug regulation, the agency has issued an interpretive rule affirming its policy on the orphan drug exemption. The pharma industry is up in arms, but what does it all mean?

For many larger healthcare organizations, group purchasing has yielded significant savings. Physician practices are also mulling whether or not they can achieve savings through aggregated procurement.

Purchased services can drain a lot of money and time from an organization because it is so diverse, but a value analysis approach can clean up the disorder.

Medical device company Medtronic will catapult into the market’s stratosphere with its $42.9 billion bid to purchase rival Covidien.

The breakthrough hepatitits C drug Sovaldi has brought the high price of specialty pharma to recent public attention. But less examined are proactive approaches that could be used to curb the growth trend without depriving patients of needed therapies.

Back in January, U.S. hospitals began to experience a serious shortage of intravenous saline solutions, caused mainly by a spike in demand during the beginning of the 2013 flu season. Fast forward to May, and hospitals are still struggling with the shortage.

The healthcare industry recognizes the need to reduce its impact on the environment, yet sustainability isn't always a high priority among the decision makers at individual U.S. hospitals. Here are some ideas to help your facility get started.

When examining the cost of product procurement, delivery and distribution within a health network, executives may only be considering about half of their total supply chain spend.